-
1
-
-
84866378702
-
The role of mutations in epigenetic regulators in myeloid malignancies
-
Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012;12:599-612.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 599-612
-
-
Shih, A.H.1
Abdel-Wahab, O.2
Patel, J.P.3
Levine, R.L.4
-
2
-
-
65349118891
-
Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis
-
Pendino F, Nguyen E, Jonassen I, Dysvik B, Azouz A, Lanotte M, Ségal-Bendirdjian E, Lillehaug JR. Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis. Blood 2009;113:3172-81.
-
(2009)
Blood
, vol.113
, pp. 3172-3181
-
-
Pendino, F.1
Nguyen, E.2
Jonassen, I.3
Dysvik, B.4
Azouz, A.5
Lanotte, M.6
Ségal-Bendirdjian, E.7
Lillehaug, J.R.8
-
3
-
-
52249087526
-
CXXC domain of human DNMT1 is essential for enzymatic activity
-
Pradhan M, Estève P-O, Chin HG, Samaranayke M, Kim G-D, Pradhan S. CXXC domain of human DNMT1 is essential for enzymatic activity. Biochemistry 2008;47:10000-9.
-
(2008)
Biochemistry
, vol.47
, pp. 10000-10009
-
-
Pradhan, M.1
Estève, P.-O.2
Chin, H.G.3
Samaranayke, M.4
Kim, G.-D.5
Pradhan, S.6
-
4
-
-
0037082439
-
The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation
-
Birke M, Schreiner S, García-Cuéllar M-P, Mahr K, Titgemeyer F, Slany RK. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res 2002;30:958-65.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 958-965
-
-
Birke, M.1
Schreiner, S.2
García-Cuéllar, M.-P.3
Mahr, K.4
Titgemeyer, F.5
Slany, R.K.6
-
5
-
-
1842505317
-
Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains
-
Jørgensen HF, Ben-Porath I, Bird AP. Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol Cell Biol 2004;24:3387-95.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 3387-3395
-
-
Jørgensen, H.F.1
Ben-Porath, I.2
Bird, A.P.3
-
6
-
-
0035976968
-
Identification and characterization of the DNA binding domain of CpG-binding protein
-
Lee JH, Voo KS, Skalnik DG. Identification and characterization of the DNA binding domain of CpG-binding protein. J Biol Chem 2001;276:44669-76.
-
(2001)
J Biol Chem
, vol.276
, pp. 44669-44676
-
-
Lee, J.H.1
Voo, K.S.2
Skalnik, D.G.3
-
7
-
-
79955948324
-
Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells
-
Xu Y, Wu F, Tan L, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011;42:451-64.
-
(2011)
Mol Cell
, vol.42
, pp. 451-464
-
-
Xu, Y.1
Wu, F.2
Tan, L.3
-
8
-
-
63649102227
-
CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells
-
Andersson T, Södersten E, Duckworth JK, Cascante A, Fritz N, Sacchetti P, Cervenka I, Bryja V, Hermanson O. CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells. J Biol Chem 2009;284:3672-81.
-
(2009)
J Biol Chem
, vol.284
, pp. 3672-3681
-
-
Andersson, T.1
Södersten, E.2
Duckworth, J.K.3
Cascante, A.4
Fritz, N.5
Sacchetti, P.6
Cervenka, I.7
Bryja, V.8
Hermanson, O.9
-
9
-
-
77951986098
-
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway
-
Kim MS, Yoon SK, Bollig F, et al. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. J Biol Chem 2010;285:14585-93.
-
(2010)
J Biol Chem
, vol.285
, pp. 14585-14593
-
-
Kim, M.S.1
Yoon, S.K.2
Bollig, F.3
-
10
-
-
77950287628
-
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML
-
Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010;327:1650-3.
-
(2010)
Science
, vol.327
, pp. 1650-1653
-
-
Wang, Y.1
Krivtsov, A.V.2
Sinha, A.U.3
North, T.E.4
Goessling, W.5
Feng, Z.6
Zon, L.I.7
Armstrong, S.A.8
-
11
-
-
0034177514
-
Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31
-
Horrigan SK, Arbieva ZH, Xie HY, Kravarusic J, Fulton NC, Naik H, Le TT, Westbrook CA. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood 2000;95:2372-7.
-
(2000)
Blood
, vol.95
, pp. 2372-2377
-
-
Horrigan, S.K.1
Arbieva, Z.H.2
Xie, H.Y.3
Kravarusic, J.4
Fulton, N.C.5
Naik, H.6
Le, T.T.7
Westbrook, C.A.8
-
12
-
-
33846113924
-
a, Issa J-P, Clarke MF, Look a T. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation
-
Liu TX, Becker MW, Jelinek J, Wu W-S, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ. a, Issa J-P, Clarke MF, Look a T. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med 2007;13:78-83.
-
(2007)
Nat Med
, vol.13
, pp. 78-83
-
-
Liu, T.X.1
Becker, M.W.2
Jelinek, J.3
Wu, W.-S.4
Deng, M.5
Mikhalkevich, N.6
Hsu, K.7
Bloomfield, C.D.8
Stone, R.M.9
DeAngelo, D.J.10
-
13
-
-
38349088899
-
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
-
Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008;451:335-9.
-
(2008)
Nature
, vol.451
, pp. 335-339
-
-
Ebert, B.L.1
Pretz, J.2
Bosco, J.3
-
14
-
-
73849121794
-
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype
-
Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 2010;16:49-58.
-
(2010)
Nat Med
, vol.16
, pp. 49-58
-
-
Starczynowski, D.T.1
Kuchenbauer, F.2
Argiropoulos, B.3
-
15
-
-
34547474047
-
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients
-
Pellagatti A, Jädersten M, Forsblom A-M, et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc Natl Acad Sci USA 2007;104:11406-11.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 11406-11411
-
-
Pellagatti, A.1
Jädersten, M.2
Forsblom, A.-M.3
-
16
-
-
77951757238
-
Haploinsufficiency of Apc leads to ineffective hematopoiesis
-
Wang J, Fernald AA, Anastasi J, Le Beau MM, Qian Z. Haploinsufficiency of Apc leads to ineffective hematopoiesis. Blood 2010;115:3481-8.
-
(2010)
Blood
, vol.115
, pp. 3481-3488
-
-
Wang, J.1
Fernald, A.A.2
Anastasi, J.3
Le Beau, M.M.4
Qian, Z.5
-
17
-
-
34547092452
-
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders
-
Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 2007;110:719-26.
-
(2007)
Blood
, vol.110
, pp. 719-726
-
-
Joslin, J.M.1
Fernald, A.A.2
Tennant, T.R.3
Davis, E.M.4
Kogan, S.C.5
Anastasi, J.6
Crispino, J.D.7
Le Beau, M.M.8
|